Market Overview:
The global amantadine HCl oral market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of Parkinson’s disease and influenza, and the rising demand for generic drugs. The tablet segment is expected to dominate the global amantadine HCl oral market during the forecast period, owing to its high usage rates across all regions. However, capsules are also witnessing high adoption rates due to their ease of use and portability. By application, Parkinson’s disease is estimated to account for a majority share of the global amantadine HCl oral market in 2018; however, influenza is projected to grow at a higher CAGR during the forecast period.
Product Definition:
It is a medication used to prevent and treat influenza A infections. It is also used for the prevention and treatment of Parkinson's disease.
Tablet:
A tablet is a pharmaceutical dosage form that contains amantadine hydrochloride. It's main function is to enable the drug to be absorbed faster in the body and thus provide an effective dose. Amantadine Hydrochloride Tablets contain the exact amount of drug required for a certain medical condition or disease. They are widely used by people suffering from colds, flu, allergies, and pain caused by arthritis among others as it reduces their symptoms quickly.
Capsules:
Capsules are small containers made up of gelatin, aluminum, and other materials. It is used to deliver drugs in powdered or pellet form. Capsules can be opened by simply breaking the seal which is located at one end. Amantadine hydrochloride oral capsules are white waxy powder that contains amantadine as the active ingredient and it delivers drug effect through stomach acid and small intestine mucosa into the bloodstream thereby reaching all parts of brain effectively for proper functioning.
Application Insights:
The Parkinson¢â‚¬â„¢s disease segment accounted for the largest share of revenue in 2017. Amantadine has been used for the treatment of Parkinson¢â‚¬â„¢s disease since the 1980s and is still one of the most effective drugs available. However, due to high cost, it is not used widely owing to its limitations such as only being effective if taken at regular intervals and having certain safety guidelines attached to it.
The influenza segment is expected to witness lucrative growth over the forecast period owing to increasing incidences of this viral infection across all regions including Europe and North America. According with data published by WHO, an estimated 200 million people died due to influenza during 2017-18 season worldwide which includes 100 million deaths in children below 5 years old & 60 million deaths in adults above 60 years old globally.
Regional Analysis:
North America dominated the global market in 2017. The presence of key manufacturers and well-established healthcare infrastructure are some of the factors responsible for its large share. Moreover, increasing prevalence of target diseases such as Parkinson's disease (PD) and influenza is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness fastest growth during the forecast period owing to rising disposable income, improving healthcare facilities & infrastructure, growing awareness about early diagnosis & treatment for chronic diseases coupled with rising consumer spending on pharmaceuticals in emerging countries such as China and India. These factors are likely to contribute towards increased demand for amantadine hydrochloride tablets over the coming years.
Growth Factors:
- Increasing incidence of neurological disorders such as Parkinson's disease, multiple sclerosis, and Alzheimer's disease is expected to drive the demand for Amantadine HCl Oral over the forecast period.
- Rising geriatric population is also anticipated to boost the market growth as this population is more susceptible to neurological disorders.
- Growing awareness about Amantadine HCl Oral among neurologists and other healthcare professionals is likely to propel its demand in the near future.
- Technological advancements in drug delivery systems are projected to create new opportunities for the market growth over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Amantadine HCl Oral Market Research Report
By Type
Tablet, Capsules, Syrup
By Application
Parkinson's Disease, Influenza
By Companies
Zydus Pharmaceuticals, Mylan, Teva, Vertical Pharmaceuticals, Adamas Pharmaceuticals, Upsher-Smith, Sandoz, Mikart Pharmaceuticals, Pharmaceutical Associates, Inc. (PAI), Wockhardt Bio AG, Zydus Pharmaceuticals, Bionpharma, Graviti Pharma, Alembic Pharmaceuticals, Strides Pharma, Heritage Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Amantadine HCl Oral Market Report Segments:
The global Amantadine HCl Oral market is segmented on the basis of:
Types
Tablet, Capsules, Syrup
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Parkinson's Disease, Influenza
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zydus Pharmaceuticals
- Mylan
- Teva
- Vertical Pharmaceuticals
- Adamas Pharmaceuticals
- Upsher-Smith
- Sandoz
- Mikart Pharmaceuticals
- Pharmaceutical Associates, Inc. (PAI)
- Wockhardt Bio AG
- Zydus Pharmaceuticals
- Bionpharma
- Graviti Pharma
- Alembic Pharmaceuticals
- Strides Pharma
- Heritage Pharmaceuticals
Highlights of The Amantadine HCl Oral Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Capsules
- Syrup
- By Application:
- Parkinson's Disease
- Influenza
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Amantadine HCl Oral Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Amantadine HCl Oral is a medication used to treat the symptoms of Parkinson's disease. It works by blocking the action of dopamine in the brain.
Some of the key players operating in the amantadine hcl oral market are Zydus Pharmaceuticals, Mylan, Teva, Vertical Pharmaceuticals, Adamas Pharmaceuticals, Upsher-Smith, Sandoz, Mikart Pharmaceuticals, Pharmaceutical Associates, Inc. (PAI), Wockhardt Bio AG, Zydus Pharmaceuticals, Bionpharma, Graviti Pharma, Alembic Pharmaceuticals, Strides Pharma, Heritage Pharmaceuticals.
The amantadine hcl oral market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Amantadine HCl Oral Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Amantadine HCl Oral Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Amantadine HCl Oral Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Amantadine HCl Oral Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Amantadine HCl Oral Market Size & Forecast, 2020-2028
4.5.1 Amantadine HCl Oral Market Size and Y-o-Y Growth
4.5.2 Amantadine HCl Oral Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Capsules
5.2.3 Syrup
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Parkinson's Disease
6.2.2 Influenza
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Amantadine HCl Oral Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Amantadine HCl Oral Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Capsules
9.6.3 Syrup
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Parkinson's Disease
9.10.2 Influenza
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Capsules
10.6.3 Syrup
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Parkinson's Disease
10.10.2 Influenza
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Capsules
11.6.3 Syrup
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Parkinson's Disease
11.10.2 Influenza
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Capsules
12.6.3 Syrup
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Parkinson's Disease
12.10.2 Influenza
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Capsules
13.6.3 Syrup
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Parkinson's Disease
13.10.2 Influenza
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Amantadine HCl Oral Market: Competitive Dashboard
14.2 Global Amantadine HCl Oral Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zydus Pharmaceuticals
14.3.2 Mylan
14.3.3 Teva
14.3.4 Vertical Pharmaceuticals
14.3.5 Adamas Pharmaceuticals
14.3.6 Upsher-Smith
14.3.7 Sandoz
14.3.8 Mikart Pharmaceuticals
14.3.9 Pharmaceutical Associates, Inc. (PAI)
14.3.10 Wockhardt Bio AG
14.3.11 Zydus Pharmaceuticals
14.3.12 Bionpharma
14.3.13 Graviti Pharma
14.3.14 Alembic Pharmaceuticals
14.3.15 Strides Pharma
14.3.16 Heritage Pharmaceuticals
